Table 3.
Association factors for ICS and subscores.
| n = 64 | Total ICS | Inner resilience coherence | Thermo coherence | ||||||
|---|---|---|---|---|---|---|---|---|---|
| estimate | SE | p-value | estimate | SE | p-value | estimate | SE | p-value | |
| demographic variables | |||||||||
| Age | -0.135 | 0.092 | 0.147 | -0.099 | 0.081 | 0.226 | -0.053 | 0.027 | 0.055 |
| BMI | -0.384 | 0.159 | 0.019 ∗ | -0.362 | 0.142 | 0.014 ∗ | -0.035 | 0.047 | 0.458 |
|
| |||||||||
| Hormonal status | |||||||||
| Pre-menopausal | reference | reference | reference | ||||||
| Peri-menopausal | -7.638 | 3.037 | 0.015 ∗ | -6.930 | 2.716 | 0.013 ∗ | -0.357 | 0.903 | 0.694 |
| Post-menopausal | 4.705 | 2.536 | 0.069 | 3.604 | 2.237 | 0.112 | 1.507 | 0.707 | 0.037 ∗ |
|
| |||||||||
| Group | Decision | Decision | |||||||
| Reference | CTX | no VA- | no CTX- | ||||||
| CTX+VA | -2.691 | 1.852 | 0.152 | -3.076 | 1.580 | 0.056 | 2.000 | 0.697 | 0.006 ∗∗ |
| VA | -7.521 | 2.574 | 0.005 ∗∗ | VA-therapy | CTX | ||||
Multivariable linear regression analyses using R-statistics were performed for decision making and the total-ICS, the inner resilience coherence, and thermo coherence at T0. CTX group: patients treated only with guideline-oriented CTX; CTX+VA group: patients treated with a combination CTX and add-on VA-extracts; VA-group: patients rejecting CTX but receiving add-on VA-extracts.